Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:43:50 EDT Tue 15 Jul 2025
Enter Symbol
or Name
USA
CA



Q:APDN - APPLIED DNA SCIENCES INC - https://www.adnas.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
APDN - Q6.04.75·4.900.34.98-0.26-5.057.32511,1245.28  5.28  4.882,655.00  4.36518:09:56Jul 0715 min RT 2¢

Recent Trades - Last 10 of 1124
Time ETExPriceChangeVolume
18:09:56Q4.90-0.34100
18:02:14Q4.90-0.349
17:54:08Q4.90-0.3463
17:50:22Q4.90-0.341
17:45:43Q4.90-0.345
17:44:54Q4.90-0.341
17:44:13Q4.90-0.345
17:42:56Q4.90-0.341
17:39:15Q4.90-0.3415
17:38:40Q4.90-0.3410

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-07 09:00U:APDNNews ReleaseApplied DNA Regains Compliance with All Nasdaq Continued Listing Requirements
2025-06-30 09:00U:APDNNews ReleaseApplied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
2025-06-17 16:10U:APDNNews ReleaseApplied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward
2025-06-16 09:00U:APDNNews ReleaseApplied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
2025-05-29 16:05U:APDNNews ReleaseApplied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17
2025-05-29 08:00U:APDNNews ReleaseApplied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025
2025-05-15 16:07U:APDNNews ReleaseApplied DNA Reports Second Quarter Fiscal 2025 Financial Results
2025-05-14 11:31U:APDNNews ReleaseApplied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3
2025-04-21 09:02U:APDNNews ReleaseApplied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
2025-04-08 09:03U:APDNNews ReleaseApplied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
2025-04-01 09:46U:APDNNews ReleaseApplied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
2025-03-26 09:02U:APDNNews ReleaseApplied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
2025-03-12 08:05U:APDNNews ReleaseApplied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
2025-02-13 16:05U:APDNNews ReleaseApplied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
2025-02-12 12:02U:APDNNews ReleaseApplied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
2025-02-11 08:33U:APDNNews ReleaseApplied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
2025-01-10 09:02U:APDNNews ReleaseApplied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
2025-01-08 16:31U:APDNNews ReleaseApplied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
2024-12-18 09:02U:APDNNews ReleaseApplied DNA Customer UHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
2024-12-17 16:06U:APDNNews ReleaseApplied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines